Bharat Parenterals Ltd Financials
Company Logo

Bharat Parenterals Ltd Financial Statement

Bharat Parenterals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue69.05
Operating Expense58.79
Net Profit5.49
Net Profit Margin7.95
Earning Per Share7.90
EBIDTA10.50
Effective Tax Rate23.20

Bharat Parenterals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual254.16
Operating Expenses Annual225.73
Operating Profit Annual40.39
Interest Annual3.19
Depreciation6.40
Net Profit Annual22.59
Tax Annual8.21

Bharat Parenterals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning6.34
Cash Flow from Operations-22.92
Cash Flow from Investing-16.10
Cash Flow from Financing34.17
Cash Flow at the End1.50

Bharat Parenterals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)14.52
PBIT Margin (%)12.26
PBT Margin (%)9.14
Net PROFIT Margin (%)7.98
Return On Networth / Equity (%)11.16
Return On Networth /Employed (%)12.94
Return On Assets (%)8.45
Total Debt / Equity (X)0.32
Asset Turnover Ratio (%)1.06

Bharat Parenterals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual38.47
Total Current Assets Annual218.16
Non Current Assets Annual168.99
Total Shareholders Funds Annual213.61
Total Assets Annual387.15

Bharat Parenterals Ltd Earning Calls

EPS (INR)

Expected

0.00

Reported

-27.00

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by -195.91%

Dec 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 5, 2024, Bharat Parenterals Ltd has a market capitalization of 653.08 Cr. Value Research classifies it as a Small-Cap company.
Yes, Bharat Parenterals Ltd is debt-free with a debt-to-equity ratio of 0.39.
In FY 2023 , Bharat Parenterals Ltd recorded a total revenue of approximately 254.16 Cr marking a significant milestone in the company's financial performance.
Bharat Parenterals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.6% and 0.1% annually, respectively..
Bharat Parenterals Ltd's current PE ratio is 28.91.
Bharat Parenterals Ltd's ROCE averaged 14.1% from the FY ending March 2022 to 2024, with a median of 14.5%. It peaked at 16.2% in March 2022, reflecting strong capital efficiency over the period..
Bharat Parenterals Ltd's latest EBIT is Rs. 33.99 Cr, surpassing the average EBIT of Rs. 32.56 Cr over the 5 years..